Employee Benefit Plans - Valuation of Employee Share-Based Awards - Employee Stock Purchase Rights (Details) - Employee Stock Purchase Rights - $ / shares |
12 Months Ended | ||
|---|---|---|---|
Jul. 25, 2026 |
Jul. 26, 2025 |
Jul. 27, 2024 |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Expected volatility | 22.70% | 22.50% | 28.30% |
| Risk-free interest rate | 4.90% | 5.00% | 2.90% |
| Expected dividend | 3.30% | 3.30% | 3.50% |
| Expected life (in years) | 1 year 3 months 18 days | 1 year 3 months 18 days | 1 year 2 months 12 days |
| Weighted-average estimated grant date fair value per share (in dollars per share) | $ 12.52 | $ 12.18 | $ 11.59 |
| X | ||||||||||
- Definition The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The risk-free interest rate assumption that is used in valuing an option on its own shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Rate of weighted-average expected volatility for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|